Diamyd trials update

Much has happened in the last few months.
Here is a picture to illustrate the trials currently ongoing and when they (if data is available) will present the results.

As you can see, Phase III results are expected in fall 2010, and FDA/EMEA approval (if granted) is expected to take 6-9 months.

Click on the image to make it larger.